Cargando…
A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients
BACKGROUND: The α/β ratio for prostate cancer is postulated being in the range of 0.8 to 2.2 Gy, giving rise to the hypothesis that there may be a therapeutic advantage to hypofractionation. To do so, we carried out a randomized trial comparing hypofractionated and conventionally fractionated image-...
Autores principales: | Norkus, Darius, Karklelyte, Agata, Engels, Benedikt, Versmessen, Harijati, Griskevicius, Romas, De Ridder, Mark, Storme, Guy, Aleknavicius, Eduardas, Janulionis, Ernestas, Valuckas, Konstantinas Povilas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846611/ https://www.ncbi.nlm.nih.gov/pubmed/24007322 http://dx.doi.org/10.1186/1748-717X-8-206 |
Ejemplares similares
-
Californium versus cobalt brachytherapy combined with external-beam radiotherapy for IIB stage cervical cancer: long-term experience of a single institute
por: Janulionis, Ernestas, et al.
Publicado: (2015) -
Second malignancies following conventional or combined (252)Cf neutron brachytherapy with external beam radiotherapy for breast cancer
por: Valuckas, Konstantinas Povilas, et al.
Publicado: (2013) -
The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone
por: Grigienė, Rūta, et al.
Publicado: (2007) -
Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy
por: Versmessen, Harijati, et al.
Publicado: (2012) -
Endometrial cancer and microsatellite instability status
por: Kanopiene, Daiva, et al.
Publicado: (2014)